Categories · Health/Science
· Federal
· Cessation
non-USA, by Country · Hong Kong
Organizations · FDA
|
Jump to full article: Hong Kong Standard (hk), 2009-07-03 Author: Beatrice Siu and agencies
Intro: Two drugs to help smokers kick the habit will continue to be sold in Hong Kong despite claims they may trigger depression or induce suicidal thoughts.
. . .
A spokeswoman for the Hospital Authority said Champix is a self- financed medicine, but added frontline medical staff will heed FDA warnings.
Pfizer Corporate Affairs director Geraldine Ip Pui-see said depression and suicidal tendencies are among symptoms contained in the drug description.
Jump to full article » |